These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

940 related items for PubMed ID: 2946711

  • 1. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 3. Ovarian sonographic findings during intermittent intranasal luteinizing hormone-releasing hormone agonist sequentially combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A, Faure N, Bastide A.
    Fertil Steril; 1987 Jan; 47(1):60-6. PubMed ID: 2947818
    [Abstract] [Full Text] [Related]

  • 4. Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach.
    Lemay A, Jean C, Faure N.
    Fertil Steril; 1987 Nov; 48(5):775-82. PubMed ID: 2959569
    [Abstract] [Full Text] [Related]

  • 5. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H, Jung C, Taubert HD.
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [Abstract] [Full Text] [Related]

  • 6. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W, Schmidt-Gollwitzer K, Nevinny-Stickel J, Schmidt-Gollwitzer M.
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [Abstract] [Full Text] [Related]

  • 7. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 8. Ovulation inhibition with nafarelin acetate nasal administration for six months.
    Brenner PF, Shoupe D, Mishell DR.
    Contraception; 1985 Dec; 32(6):531-51. PubMed ID: 2936564
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Dec; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 10. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 11. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

  • 12. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 13. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
    Fraser HM, Dewart PJ, Smith SK, Cowen GM, Sandow J, McNeilly AS.
    J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
    [Abstract] [Full Text] [Related]

  • 14. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 15. Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: an alternative protocol for contraception.
    Chryssikopoulos A, Phocas I, Rizos D, Kontoravdis A.
    Gynecol Endocrinol; 1997 Apr; 11(2):119-26. PubMed ID: 9174853
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 17. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul 15; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 18. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec 15; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 19. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T, Reymond M, Rappoport G, Magrini G, Gomez J.
    Pathol Biol (Paris); 1975 Dec 15; 23(10):917-22. PubMed ID: 772543
    [Abstract] [Full Text] [Related]

  • 20. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov 15; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.